Ontology highlight
ABSTRACT:
SUBMITTER: Hofmann S
PROVIDER: S-EPMC6406805 | biostudies-literature | 2019 Feb
REPOSITORIES: biostudies-literature
Hofmann Susanne S Schubert Maria-Luisa ML Wang Lei L He Bailin B Neuber Brigitte B Dreger Peter P Müller-Tidow Carsten C Schmitt Michael M
Journal of clinical medicine 20190206 2
Despite high response rates after initial chemotherapy in patients with acute myeloid leukemia (AML), relapses occur frequently, resulting in a five-year-survival by <30% of the patients. Hitherto, allogeneic hemotopoietic stem cell transplantation (allo-HSCT) is the best curative treatment option in intermediate and high risk AML. It is the proof-of-concept for T cell-based immunotherapies in AML based on the graft-versus-leukemia (GvL)-effect, but it also bears the risk of graft-versus-host di ...[more]